United Therapeutics Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| UTHR | LQDA | NBIX | VTRS | AMRX | TEVA | |
|---|---|---|---|---|---|---|
| Market cap | 23.59B | 2.48B | 14.37B | 20.15B | 6.98B | 48.02B |
| P/E (TTM) | 19.7 | 19.9 | 20.7 | — | 40.9 | 68.6 |
| Forward P/E | 16.3 | 11.9 | 11.9 | 6.6 | 16.8 | 13.4 |
| Price/book | 3.7 | 12.6 | 3.9 | 1.4 | 194.5 | 6.2 |
| Dividend yield | — | — | — | 2.72% | — | — |
| 1-year change | +24.79% | +15.19% | +3.71% | +78.90% | +106.07% | +105.29% |
| Today | +0.17% | +1.06% | −0.75% | −0.57% | +0.60% | +0.17% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All UTHR news ›Head to Head Survey: Xenon Pharmaceuticals (NASDAQ:XENE) vs. United Therapeutics (NASDAQ:UTHR)
Posted by Kim Johansen on Oct 12th, 2026 Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) and United Therapeutics (NASDAQ:UTHR – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the…
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,215,025.00 in Stock
Posted by Defense World Staff on Oct 11th, 2026 Shares of NASDAQ UTHR opened at $549.16 on Friday. United Therapeutics Corporation has a fifty-two week low of $409.07 and a fifty-two week high of $609.35. The firm has a market…
United Therapeutics Corporation (NASDAQ:UTHR) Stock Has Average Target Price of $627.31
Posted by Defense World Staff on Oct 11th, 2026 Check Out Our Latest Report on United Therapeutics United Therapeutics markets its therapies primarily in the United States and internationally through commercial and regulatory activities in…
United Therapeutics CEO trust sells 9,500 shares
After exercising 9,500 options, the CEO’s trust sells 9,500 United Therapeutics (UTHR) shares. Stock Titan - [Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity United Therapeutics CEO trust sells 9,500 shares The chairperson and…
What Does a U.S. Crystal Patent Actually Bring to UTHPEAK™ NMNH?
PDF file | Product Brochure | Promotional Content Visit Booth #5365 at SupplySide Global 2026! EffePharm is bringing UTHPEAK™ NMNH to the show. It has secured a U.S. patent on the crystalline form of reduced NMNH calcium salt. For our…
Ucommune International Announces Resignations of Chief Product Designer and CMO
Ucommune International ( (UK) ) just unveiled an update. Ucommune International Ltd is a foreign private issuer headquartered in Beijing, China, operating within the broader commercial and office services sector, with its securities…
TuHURA Biosciences, Inc. (NASDAQ:HURA) Stock Has Consensus Target Price of $9.00
Posted by Michael Walen on Oct 12th, 2026 A number of analysts have recently commented on HURA shares. Citizens Jmp restated a “market outperform” rating and set a $9.00 target price on shares of TuHURA Biosciences in a report on Tuesday,…
BC Partners eyes sale of United Group's Croatia arm to jump-start broader exit plans
BC Partners is prepping a potential divestment of United Group's operations in Croatia to reset efforts to sell the wider business, according to people familiar with the matter who asked not to be named. A formal sale process is slated to…
Monopar Therapeutics Inc. (MNPR) – What Are Researchers Saying About This Stock?
Posted by Defense World Staff on Oct 11th, 2026 View Our Latest Analysis on MNPR Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) last released its quarterly earnings results on Wednesday, August 12th. The company reported ($0.62) EPS…
United Therapeutics (NASDAQ:UTHR) Stock Gets Price Target Bump from Morgan Stanley
United Therapeutics (NASDAQ:UTHR – Get Free Report) had its price objective lifted by investment analysts at Morgan Stanley from $515.00 to $566.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has an…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
stocktitan.net24
-
tradingview.com8
-
defenseworld.net7
-
themarketsdaily.com5
-
247wallst.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 87 articles, not a forecast.